Skip links

VALIDATION

Multiple studies and commercial installations demonstrate C-POLAR™ material effectively captures, inactivates, and eradicates viruses, microorganisms, and pollens, with up to 99.99% efficiency

Lab Validation

C-POLAR™ material eradicated 92% of Staphylococcus aureus after a 10-minute incubation period. The input of pathogens was close to 100x higher than the ISO 20743:2013 standard.

92%
ERADICATION

Filters protected by C-POLAR™ significantly improved collection efficiency and substantially reduced viable bovine coronavirus concentration by 99.3% in a single-pass, fast air-flow wind tunnel.

99.3%
CAPTURE

C-POLAR™ material eradicated >99.6% of SARS-CoV-2 within 30 minutes (98% within 5 minutes). In one of the biological replicates, researchers achieved 100% virus eradication.

99.6%
ERADICATION

C-POLAR™ material eradicated >99.9% of multiple bacterial pathogens within 1 minute.

99.9%
ERADICATION

C-POLAR™ material demonstrated a viral filtration efficiency (VFE) of >99.9%.

99.9%
CAPTURE

C-POLAR™ material demonstrated a viral filtration efficiency (VFE) of >99.9%.

99.9%
CAPTURE

COMMERCIAL VALIDATION

Working in partnership with Hong Kong Metropolitan University, we installed filters protected by C-POLAR™ in five dense foot traffic locations in Hong Kong: International Commerce Center, Central Building, K11 MUSEA, 1 Duddell Street, and China Minmetals Tower.

Testing in these areas showed filters protected by C-POLAR™ demonstrated strong antibacterial efficiency of up to 99.9999% even after 60 days of intensive, real-world commercial use in bioaerosol and particulate rich environments.

Our technology’s efficacy and safety has been tested and verified by leading medical and regulatory institutions in the United States, Czech Republic, Hong Kong, Finland, and United Kingdom.​